Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

249 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Post COVID-19 irritable bowel syndrome.
Marasco G, Cremon C, Barbaro MR, Cacciari G, Falangone F, Kagramanova A, Bordin D, Drug V, Miftode E, Fusaroli P, Mohamed SY, Ricci C, Bellini M, Rahman MM, Melcarne L, Santos J, Lobo B, Bor S, Yapali S, Akyol D, Sapmaz FP, Urun YY, Eskazan T, Celebi A, Kacmaz H, Ebik B, Binicier HC, Bugdayci MS, Yağcı MB, Pullukcu H, Kaya BY, Tureyen A, Hatemi İ, Koc ES, Sirin G, Calıskan AR, Bengi G, Alıs EE, Lukic S, Trajkovska M, Hod K, Dumitrascu D, Pietrangelo A, Corradini E, Simren M, Sjölund J, Tornkvist N, Ghoshal UC, Kolokolnikova O, Colecchia A, Serra J, Maconi G, De Giorgio R, Danese S, Portincasa P, Di Sabatino A, Maggio M, Philippou E, Lee YY, Salvi D, Venturi A, Borghi C, Zoli M, Gionchetti P, Viale P, Stanghellini V, Barbara G; GI-COVID19 study group. Marasco G, et al. Among authors: maconi g. Gut. 2022 Dec 9:gutjnl-2022-328483. doi: 10.1136/gutjnl-2022-328483. Online ahead of print. Gut. 2022. PMID: 36591612
Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy.
Tursi A, Mocci G, Cuomo A, Ferronato A, Elisei W, Picchio M, Maconi G, Scaldaferri F, Papa A; Italian group for switch of biologics; Allegretta L, Aragona G, Bianco MA, Colucci R, Della Valle N, Faggiani R, Forti G, Gaiani F, Giorgetti G, Graziani MG, Lofano K, Lorenzetti R, Larussa T, Penna A, Bassotti G, Cazzato AI, Chiri S, Clemente V, Cocco A, De' Angelis G, Donnarumma L, Graziosi C, Le Grazie M, Luzza F, Meucci C, Monterubbianesi R, Pagnini C, Perazzo P, Pica R, Pranzo G, Rodino' S, Sacco R, Sebkova L, Scarcelli A, Serio M, Napolitano D, Pugliese D, Schiavoni E, Turchini L, Armuzzi A, Zampaletta C. Tursi A, et al. Among authors: maconi g. J Gastrointestin Liver Dis. 2022 Dec 16;31(4):411-416. doi: 10.15403/jgld-4608. J Gastrointestin Liver Dis. 2022. PMID: 36535057 Free article.
Continuous clinical remission with biologics in ulcerative colitis: the 'AURORA' comparison study.
Cassinotti A, Mezzina N, De Silvestri A, Di Paolo D, Lenti MV, Bezzio C, Stradella D, Mauri M, Zadro V, Ricci C, Casini V, Radice E, Massari A, Maconi G, Saibeni S, Caprioli F, Tari R, Fichera M, Cortelezzi CC, Parravicini M, Tinelli C, Testoni PA, Pace F, Segato S, Invernizzi P, Occhipinti P, Manes G, Di Sabatino A, Pastorelli L, Vecchi M, Ardizzone S. Cassinotti A, et al. Among authors: maconi g. Eur J Gastroenterol Hepatol. 2022 Dec 1;34(12):1238-1246. doi: 10.1097/MEG.0000000000002443. Epub 2022 Sep 23. Eur J Gastroenterol Hepatol. 2022. PMID: 36165081
The impact of biologic therapies on extra-intestinal manifestations in inflammatory bowel disease: A multicenter study.
Ferretti F, Monico MC, Cannatelli R, Carmagnola S, Lenti MV, Di Sabatino A, Conforti F, Pastorelli L, Caprioli F, Bezzio C, Saibeni S, Mazza S, Vecchi M, Maconi G, Ardizzone S. Ferretti F, et al. Among authors: maconi g. Front Med (Lausanne). 2022 Aug 8;9:933357. doi: 10.3389/fmed.2022.933357. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36004370 Free PMC article.
Colonic Acquired Fistulae: The Potential of CT Colonography.
Flor N, Scolari S, Liedenbaum M, Maconi G, Colombo F, Maffioli A, Bondurri A, Crespi M. Flor N, et al. Among authors: maconi g. Acad Radiol. 2022 Aug 3:S1076-6332(22)00379-8. doi: 10.1016/j.acra.2022.07.006. Online ahead of print. Acad Radiol. 2022. PMID: 35933280
Adalimumab Biosimilar GP2017 versus Adalimumab Originator in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study.
Mocci G, Bodini G, Allegretta L, Cazzato AI, Chiri S, Aragona G, Perazzo P, Ferronato A, Graziani MG, Pagnini C, Zampaletta C, Graziosi C, Picchio M, Elisei W, Maconi G, Tursi A. Mocci G, et al. Among authors: maconi g. Biomedicines. 2022 Jul 26;10(8):1799. doi: 10.3390/biomedicines10081799. Biomedicines. 2022. PMID: 35892698 Free PMC article.
Professional Standards in Medical Ultrasound - EFSUMB Position Paper (Short Version) - General Aspects.
Wüstner M, Radzina M, Calliada F, Cantisani V, Havre RF, Jenderka KV, Kabaalioğlu A, Kocian M, Kollmann C, Künzel J, Lim A, Maconi G, Mitkov V, Popescu A, Saftoiu A, Sidhu PS, Jenssen C. Wüstner M, et al. Among authors: maconi g. Ultraschall Med. 2022 Oct;43(5):456-463. doi: 10.1055/a-1854-2936. Epub 2022 Jul 18. Ultraschall Med. 2022. PMID: 35850146 Free article. English.
Professional Standards in Medical Ultrasound - EFSUMB Position Paper (Long Version) - General Aspects.
Wüstner M, Radzina M, Calliada F, Cantisani V, Havre RF, Jenderka KV, Kabaalioğlu A, Kocian M, Kollmann C, Künzel J, Lim A, Maconi G, Mitkov V, Popescu A, Saftoiu A, Sidhu PS, Jenssen C. Wüstner M, et al. Among authors: maconi g. Ultraschall Med. 2022 Oct;43(5):e36-e48. doi: 10.1055/a-1857-4435. Epub 2022 Jul 18. Ultraschall Med. 2022. PMID: 35850145 Free article. English.
249 results